Cynvenio Biosystems, Inc. announced it has hired Paul Y. Song, M.D., as Chief Medical Officer to oversee translational and clinical research programs at Cynvenio. Dr. Song will be responsible for global clinical utility activities including trial definition, institutional partner selection and patient stratification. He will also coordinate global activities with partners abroad, especially in Europe and China.

Dr. Song is also on the faculty at Cedars Sinai Medical Center, in the Samuel Oschin Cancer Center department of radiation oncology and biomedical sciences. He also serves as Chief Medical Officer at AT-Gen Co. Ltd.